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1. Introduction 
Pyruvate kinase (ATP: pyruvate phosphotrans- 
ferase, EC 2.7.1.40) has been widely recognized as an 
important regulatory enzyme in a variety of organisms 
[ 1,2] . In previous reports on pyruvate kinase of 
Neurospora, this enzyme has been shown to be sub- 
ject to regulation by a number of positive and nega- 
tive allosteric modifiers [3] . The occurrence of con- 
formational changes induced by substrates and the 
allosteric effector, FDP, has been demonstrated by 
differential proteolysis [4] , response towards protein 
denaturants [5], studies of intrinsic protein fluores- 
cence [4] and interaction with the hydrophobic 
fluorescent probe, ANS [6,7]. 
Investigations into the interaction of Neurospora 
pyruvate kinase and FDP demonstrated a marked 
reduction in the tryptophanyl fluorescence and a 
displacement of a substantial fraction of bound ANS 
[4,6] suggesting the implication of aromatic residues 
and nonpolar amino acid side chains in the regulatory 
region. Pyruvate kinase, a tetramer [3], contains a 
total of 3 tryptophan residues per monomer, of 
which two are available for modification by N- 
bromosuccinimide in the native state (submitted 
paper). The nonequivalence of the environment of 
individual tryptophans, thus indicated, can be 
exploited to gain further insight into the nature of 
the structural changes triggered by FDP. 
In this work we have examined the consequence 
Abbreviations: FDP, fructose 1,6_diphosphate; ANS, 
8-aniline-1-naphthalene sulfonate. 
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of binding of FDP to pyruvate kinase using the 
sensitive technique of UV difference spectroscopy. 
A pronounced perturbation of the environment of 
aromatic residues was observed. 
2. Materials and methods 
Pyruvate kinase was isolated from a wild-type 
strain (FGSC No. 262) of Neurospora crassa and 
purified to homogeneity, stored and assayed as 
described earlier [8]. Protein determinations were 
conducted according to the methods of Lowry et al. 
[9] and Babul and Stellwagen [IO] , with fatty-acids- 
free bovine serum albumin as a standard. Just prior to 
use the protein solutions were diluted with 0.1 M 
phosphate buffer, pH 7.5, dialyzed against 200 vol 
of the same buffer for 2 h and clarified by centri- 
fugation at 27 000 g for 15 min. 
UV difference spectra were measured employing a 
Cary Model 15 spectrophotometer. The photomulti- 
plier dynode and sensitivity settings were 2 and 3, 
respectively. A set of matched, rectangular, quartz 
tandem cells (Hellma) with light path of 0.437 cm 
were used. The arrangement of compartments in the 
cells was as follows: compartments 1 and 2 were 
placed in the sample beam, 1 being closest to the 
monochromator; compartments 3 and 4 were in the 
reference beam. Compartments 2 and 4 always con- 
tained protein samples; 1 and 3 contained the refer- 
ence solutions. Difference spectra were recorded 
from 2.50 nm to 340 nm on a full scale of 0.1 absor- 
bance unit, at room temperature. Aliquots of the 
desired ligand were added sequentially to compart- 
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ments 2 and 3 with Hamilton microsyringes, identical 
volumes of the buffer being added to compartments 
1 and 4 at the same time. 
3. Results 
The difference spectra induced by the binding of 
FDP to Neurospora pyruvate kinase are presented in 
fig. 1. These spectra show two clearly distinguishable 
minima located at 294 nm and 286.5 nm, a third less 
well-defined one in the vicinity of 277 nm and maxi- 
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Fig.2. The difference spectra caused by the sequential 
addition of valine to pyruvate kinase. For the baseline spec- 
trum (A) 1.0 ml pyruvate kinase (1.51 mg/ml) was added to 
compartments 2 and 4 and 1.0 ml of 0.1 M phosphate buffer, 
pH 7.5, to compartments 1 and 3. For ligand-promoted 
spectra, valine was added to a final concentration of 9.9 PM 
and 0.476 mM for spectra B and C, respectively. Correspon- 
ding volumes of buffer solution were added to compartments 
1 and 4 each time. 
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Fig.1. The difference spectra caused by the binding of FDP 
to pyruvate kinase. Compartments 1 and 3 contained 1.0 ml 
of 0.1 M phosphate buffer, pH 7.5, and compartments 2 and 
4 contained 1.0 ml of pyruvate kinase solution at a concen- 
tration of 2.26 mg/ml for the baseline spectrum. For the 
ligand-induced spectra, aliquots of a stock solution of FDP 
were added to compartments 2 and 3; similar aliquots of 
buffer were added to compartments 1 and 4. Spectrum A, 
baseline. For spectra B, C and D, final concentrations of FDP 
were: 9.9 PM (B); 19.6 PM (C); and 47.6 PM (D). 
ma at 279 and 272 nm. The two major negative peaks 
exhibited an increase in amplitude in the presence of 
increasing concentrations of FDP; the third peak also 
appeared to follow the same general trend albeit in a 
weak manner. At saturating levels of FDP, Ae values 
of -6450 and -2700 were calculated for the 294 nm 
and 286.5 nm peaks, respectively. 
The spectral effects mentioned above are charac- 
teristic of perturbations in the environment of aro- 
matic residues. The minimum at the longer wavelength 
can be ascribed to perturbation of tryptophan but 
that at 286.5 nm could be due either to tryptophan 
or tyrosine, or due to contributions from both; it is 
difficult to distinguish unambiguously between the 
two at this wavelength [ 11,121. The third, inconspic- 
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uous, peak at 2766277 nm is likely to be generated of the tryptophan residues appear to be localized on 
by a perturbation of tyrosyl residues. The origin of the surface of pyruvate kinase. Therefore, even a 
the positive peak in the neighbourhood of 270 nm is small conformational change would be sufficient to 
not certain. cause a marked perturbation. 
Pyruvate kinase has previously been shown to be 
regulated by valine, a potent inhibitor of the enzyme 
[3] . Therefore, the effect of valine on the UV absor- 
bance properties of this enzyme was also examined by 
difference spectroscopy. As illustrated in fig.2 valine, 
upon binding to the enzyme did not give rise to a 
well-resolved difference spectrum comparable to that 
produced by FDP. At saturation (Spectrum C), two 
barely discernible minima centered at 290 nm and 
282 nm were observable. This suggests that only a 
weak perturbation of aromatic residues, which are 
affected by FDP, is generated by valine. As the 
concentrations of valine and FDP employed were 
commensurate with levels appropriate for their 
regulatory function, the existence of separate binding 
sites for these two ligands is indicated. 
The binding of FDP to pyruvate kinase also results 
in an increase in the enzyme’s negative charge. It is 
important to obtain an estimate of the distances 
between bound FDP, aromatic residues and other 
charged groups in the allosteric sites, for if these 
perturbations were attributable to an altered electro- 
static enviroment the aromatic residues should be 
very close to the charged groups involved [ 121. 
Structural changes associated with the binding of 
substrates, Mg” and phenylalanine, an inhibitor, 
have been recorded for muscle pyruvate kinase by 
difference spectroscopy [13-l 51. 
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4. Discussion 
The results documented in this communication 
present evidence for a perturbation in the environ- 
ment of aromatic residues as a consequence of bin- 
ding of the allosteric effector, FDP, to pyruvate 
kinase. Studies of intrinsic fluorescence‘and inter- 
action with ANS indicated the implication of trypto- 
phan residues in the FDP binding region and the 
presence of apolar side chains at or near this site [7]. 
The previously reported quenching of aromatic 
fluorescence, subsequent to the binding of FDP, can 
be explained on the basis of the positioning of specif- 
ic quenching groups in their proximity or a material 
alteration in their environment, resulting from a 
ligand-induced conformational change. 
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